4-Methylmorpholine → methyl N-[(5-amino-1-methyl-3-phenyl-1H-indol-2-yl)carbonyl]-L-leucinate
Reaction equation
[CH3:1][N:2]1[C:10]2[C:5](=[CH:6][C:7]([N+:11]([O-])=O)=[CH:8][CH:9]=2)[C:4]([C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)=[C:3]1[C:20](O)=[O:21].Cl.CN(C)CCCN=C=NCC.Cl.[CH3:36][O:37][C:38](=[O:45])[C@H:39]([CH2:41][CH:42]([CH3:44])[CH3:43])[NH2:40].CN1CCOCC1.NN>C(Cl)Cl.[Ni]>[NH2:11][C:7]1[CH:6]=[C:5]2[C:10](=[CH:9][CH:8]=1)[N:2]([CH3:1])[C:3]([C:20]([NH:40][C@H:39]([C:38]([O:37][CH3:36])=[O:45])[CH2:41][CH:42]([CH3:44])[CH3:43])=[O:21])=[C:4]2[C:14]1[CH:15]=[CH:16][CH:17]=[CH:18][CH:19]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of 1-methyl-5-nitro-3-phenyl-1H-indole-2-carboxylic acid (0.56 g, 1.9 mmol), 1-[3-(dimethylamino)propyl-3-ethylcarbodiimide hydrochloride (0.47 g, 2.5 mmol), and L-leucine methyl ester hydrochloride (0.40 g, 2.2 mmol) was stirred in CH2Cl2 (20 mL). N-methylmorpholine (1.01 g, 10 mmol) was added and the mixture was stirred at room temperature overnight. The mixture was then washed with 0.05 N HCl and water. The resulting solution was dried with MgSO4 and concentrated. The residue was dissolved in 30 mL of ethanol and a large excess of Raney® nickel and hydrazine (0.6 mL, 19 mmol) were added. After stirring at room temperature for 2 h the catalyst was then removed by filtering through a short pad of Celite®521. The filtrate was concentrated to give 0.65 g (87%) of crude methyl N-[(5-amino-1-methyl-3-phenyl-1H-indol-2-yl)carbonyl]-L-leucinate as a pale yellow solid: MS (ESI) m/z 394 (MH+); HRMS calcd for C23H28N3O3: 394.2128; found (ESI+): 394.2121.
Workup
- washThe mixture was then washed with 0.05 N HCl and water
- dry with materialThe resulting solution was dried with MgSO4
- concentrationconcentrated
- dissolutionThe residue was dissolved in 30 mL of ethanol
- stirringAfter stirring at room temperature for 2 h the catalyst
- customwas then removed
- filtrationby filtering through a short pad of Celite®521
- concentrationThe filtrate was concentrated
Sources & evidence
- ORD record
- ord-27b7a4937bc9480fba001b45116f4be0
- Source dataset
- uspto-grants-2008_10
- Patent number
- US07442805B2
Reaction notes
Loading…